The Charité Comprehensive Cancer Center integrates the clinical and research activities for all Charité departments and institutes dealing with Cancer. The director of the Charité Comprehensive Cancer Center is Prof. Dr. med. Ulrich Keilholz.
The Department I for Internal Medicine of the University Hospital Cologne deals with the treatment of patients with various internal diseases. This includes in particular the following fields: Oncology, Hematology, Clinical infectology, Clinical immunology, Hemostasis, Intensive care.
The Department of Hematology, Oncology and Rheumatology at the Heidelberg University Hospital makes every effort to provide medical care of the highest quality to the patients with oncologic and rheumatologic diseases.
The clinic of hematology, hemostasis, oncology and stem cell transplantation is a leading therapeutic clinic of the Medical Institute of Hannover for patients with solid tumor and systemic diseases, with other partially benign diseases of the hematopoietic system, as well as bleeding disorders.
The Department specializes on internal medicine with focus on hematology and oncology. First of all, patients with acute leukemias, lymphomas and carcinomas, but also patients with non-malignant hematological diseases are treated here on an inpatient basis.
The Department of Hematology, Oncology and Clinical Immunology at the University Hospital Dusseldorf provides treatment of patients with blood diseases, cancer and immune system diseases. The Department focuses on the treatment of malignant diseases of blood, bone marrow and lymph nodes.
The Department of Hematology, Oncology, Hemostasis, Rheumatology and Infectology at the University Hospital Frankfurt specializes in the treatment of all diseases of the hymatopoietic system and solid tumors.
The Department of Hematology and Internal Oncology deals with the diagnosis and treatment of patients with disorders of the hematopoietic system, such as acute and chronic leukemia and malignant lymphomas, as well as malignant solid tumors (if chemotherapy or other systemic treatments are needed).
The Department of Medicine II treats patients with hematologic/oncologic, gastrointestinal and rheumatologic / immunological clinical pictures on both inpatient and outpatient basis. In March 2005, there was founded a new Stem Cell Transplant Center.
The Department of Internal Medicine at the University Hospital Tubingen, consisting of 8 sections, is one of few comprehensive German centers, which provide various services in the field of internal medicine at the university level. The specialists of the Department are very professional due to a long experience.
The Department of Oncology, Hematology and Stem Cell Transplant provides patient care on both inpatient and outpatient basis. The focuses of the inpatient treatment are acute leukemia and high-dose chemotherapy followed by autologous blood stem cell transplantation.
The main direction of the Clinic of Internal Medicine III at Ulm University Clinic is the care for patients with benign and malignant tumors of the blood and lymphatic system (including anemia, lymphadenopathy, acute and chronic leukemia, myelodysplastic syndrome, myeloproliferative disorders, Hodgk...
The department of hematology and oncology diagnosed and treated malignant tumors. The therapeutic spectrum includes all medicamentous treating methodes including chemotherapy, antibody, immune and hormone therapy. Cancer patients benefit from interdisciplinary treatment.